Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmarise HoldingsTSE:2796 46 Days Inventory is 22.04 as of May. 2026, which is 12% above its 10-year median of 19.75. GuruFocus rates TSE:2796 with a GF Score™ of 46/100 and a GF Value™ of 円581.07 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 502 Healthcare Providers & Services companies, Pharmarise Holdings ranks better than 57.17% on this metric.
The historical rank and industry rank for Pharmarise Holdings's Days Inventory or its related term are showing as below:
TSE:2796'
s Days Inventory Range Over the Past 10 Years
Min: 16.71 Med: 19.75 Max: 23.57
Current: 23.57
During the past 13 years, Pharmarise Holdings's highest Days Inventory was 23.57. The lowest was 16.71. And the median was 19.75.
TSE:2796's Days Inventory is ranked better than 57.17% of 502
companies
in the Healthcare Providers & Services industry
Industry Median: 29.315
vs TSE:2796: 23.57
Pharmarise Holdings's Days Inventory
declined
from May. 2025 (24.31) to May. 2026 (22.04).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pharmarise Holdings's Inventory Turnover for the
six
months ended in May. 2026 was 8.28.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pharmarise Holdings's Inventory-to-Revenue for the
six
months ended in May. 2026 was 0.10.
Pharmarise Holdings (TSE:2796) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pharmarise Holdings's Inventory Turnover for the
six
months ended in May. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pharmarise Holdings's Inventory to Revenue for the
six
months ended in May. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pharmarise Holdings Days Inventory Related Terms
Pharmarise Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Pharmarise Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmarise Holdings Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmarise Holdings Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pharmarise Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmarise Holdings (TSE:2796) has a Days Inventory of 22.04 as of May. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharmarise Holdings and its competitors. This is 12% above median its historical median of 19.75. Over the past decade, Pharmarise Holdings' Days Inventory has ranged from 16.71 to 23.57. According to the industry distribution chart, Pharmarise Holdings ranks #215 out of 502 companies in the Healthcare Providers & Services industry, placing it in the top 42.8%.
Is Pharmarise Holdings' Days Inventory too high?
Pharmarise Holdings' current Days Inventory of 22.04 is 12% above median its 10-year median of 19.75. Over the past 10 years, this metric has ranged from a low of 16.71 to a high of 23.57. The Healthcare Providers & Services industry median Days Inventory is 29.32. Pharmarise Holdings' value of 22.04 is 24.8% below this industry median. Based on the distribution chart, Pharmarise Holdings ranks #215 out of 502 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pharmarise Holdings has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharmarise Holdings' Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pharmarise Holdings ranks #215 out of 502 companies for Days Inventory. This puts Pharmarise Holdings in the upper half of its industry. The industry median Days Inventory is 29.32. Pharmarise Holdings' value of 22.04 is 24.8% below this benchmark. Historically, Pharmarise Holdings' own Days Inventory has ranged from 16.71 to 23.57 over the past decade. While the company's 10-year median is 19.75 vs. the industry median of 29.32, Pharmarise Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.32, based on 502 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmarise Holdings's current Days Inventory of 22.04 is 24.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharmarise Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmarise Holdings's current Days Inventory is 22.04, which is 12% above median its own 10-year median of 19.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmarise Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmarise Holdings (TSE:2796) is currently considered Modestly Undervalued. The stock's GF Value™ is 円581.07, compared to a current price of 円505.00 — trading 13.1% below its estimated fair value. The current Days Inventory is 22.04, which is 12% above median its 10-year median of 19.75 and 24.8% below the Healthcare Providers & Services industry median of 29.32. Pharmarise Holdings' overall GF Score™ is 46/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pharmarise Holdings (TSE:2796), the current Days Inventory is 22.04 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmarise Holdings (TSE:2796) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmarise Holdings stock appears to be undervalued.
The current stock price of 円505.00 is trading 13.1% below its estimated GF Value™ of 円581.07.
GuruFocus considers Pharmarise Holdings to be Modestly Undervalued.
Key valuation signals for TSE:2796:
Days Inventory: 22.04 (12% above median its 10-year median of 19.75)
GF Value™: 円581.07 vs. price of 円505.00 (13.1% below fair value)
Industry Position: 24.8% below the Healthcare Providers & Services median (#215 of 502)
No single metric tells the full story. See the TSE:2796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on the prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.
46GF Score
Get the complete analysis for TSE:2796
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2796 has been successfully added to your 
